国泰海通证券股份有限公司 关于吉林省西点药业科技发展股份有限公司 2025半年度持续督导跟踪报告

Group 1 - The report does not constitute any investment advice regarding listed companies [1] - The sponsor institution reminds investors to carefully read the company's audit reports and annual reports [1] Group 2 - Overview of the sponsorship work [1] - Issues identified by the sponsor and the measures taken [1] - Compliance status of company and shareholder commitments [1] - Other matters [1] - Additional explanations [1]